Zydus Lifesciences forays into Chinese mkt
November 12, 2025
|Business Standard
Zydus Lifesciences has secured its first ever Chinese market approval for its antidepressant, Venlafaxine Extended-Release (ER) capsules (75 mg and 150 mg), marking its debut in the country and furthering the Indian company’s global expansion.
Venlafaxine ER capsules are prescribed for major depressive, generalised anxiety, social anxiety, and panic disorders. The medication helps restore the balance of serotonin and norepinephrine in the brain, addressing a critical need in mental health care by improving mood and reducing anxiety. The capsules will be manufactured at Zydus’s facility in M
هذه القصة من طبعة November 12, 2025 من Business Standard.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Business Standard
Business Standard
PE-VC investments at $33 bn in '25
Mega deals slide slightly; IT and BFSI lead sector investments
1 mins
January 01, 2026
Business Standard
RBI red-flags bank-NBFC interlink risks
Banks acquiring 80% assets through a limited number of NBFCs
2 mins
January 01, 2026
Business Standard
Precious metals outshine stocks in 2025 amid global volatility
Nearly 60% of the top 1,000 listed stocks delivered negative returns
1 mins
January 01, 2026
Business Standard
Weakness in ₹, broader equity market shrinks India's billionaire club in 2025
Top IPO promoters
3 mins
January 01, 2026
Business Standard
EV Policy 2.0: Delhi govt to meet five auto firms, Siam
Meeting scheduled on Jan 2 as capital remains in a smog of pollution
2 mins
January 01, 2026
Business Standard
Year of hope
India must aim to sustain the growth momentum
2 mins
January 01, 2026
Business Standard
Eight more cos to get incentives under auto PLI
Three vehicle makers, five auto part makers to get benefits from FY27
2 mins
January 01, 2026
Business Standard
Centre notifies revised draft rules for labour codes, seeks stakeholders' responses
The Ministry of Labour and Employment on Wednesday notified the revised draft rules for the four new Labour Codes, providing clarity on certain provisions such as gratuity payments and retrenchment of workers.
1 mins
January 01, 2026
Business Standard
Oyo parent files for ₹6,650 cr IPO via confidential route
Oyo’s parent firm Prism has filed confidential draft red herring prospectus (DRHP) papers with the markets regulator to raise up to %6,650 crore through an initial public offering (IPO), which would be the third attempt by the global travel technology company at public listing.
2 mins
January 01, 2026
Business Standard
External uncertainties may trigger outflows, Fx rate volatility: RBI
The Reserve Bank of India (RBI) has cautioned that the country's economy faces near-term risks largely from external uncertainties, including the possibility of a sharp correction in US equities that could trigger foreign portfolio outflows, heighten exchange rate volatility and tighten domestic financial conditions.
2 mins
January 01, 2026
Listen
Translate
Change font size

